Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Noctura400 Treatment for Diabetic Retinopathy: Pilot Study to Demonstrate and Evaluate the Care Pathway for National Health Service (NHS) Adoption

NCT02207712 is registered in ClinicalTrials.gov with PolyPhotonix Medical as lead sponsor.

NCT NCT02207712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02207712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Noctura400 Treatment for Diabetic Retinopathy: Pilot Study to Demonstrate and Evaluate the Care Pathway for National Health Service (NHS) Adoption
Lead sponsor
PolyPhotonix Medical
Phase
Not applicable
Overall status
Terminated
Start date
November 30, 2014
Completion date
August 31, 2023
Enrollment
252 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular oedema